Key result
Laparoscopic sleeve gastrectomy is linked to reduced BMI despite increased gastric volume, with ~7% complications.
Why the study?
Does laparoscopic sleeve gastrectomy reduce BMI and improve comorbidities in patients with morbid obesity?
Cohort (n=73)
No
Does laparoscopic sleeve gastrectomy reduce BMI and improve comorbidities in patients with morbid obesity?
p-value: p=< 0.001
Laparoscopic sleeve gastrectomy is a safe and effective procedure for weight reduction and comorbidity improvement in morbidly obese patients over a 12-month period.
Supports short-term BMI reduction after sleeve gastrectomy in morbid obesity; leaves open long-term durability, comorbidity effects, and causal confirmation in RCTs.
BACKGROUND: Laparoscopic sleeve gastrectomy is a surgical procedure for the treatment of morbid obesity. However, there are still controversies regarding its efficiency in terms of weight reduction and incidence of complications. In this prospective study, the experience is presented of a referral centre for the treatment of morbid obesity with laparoscopic sleeve gastrectomy. MATERIAL AND METHODS: A prospective study on 73 patients subjected to laparoscopic sleeve gastrectomy from February 2009 to September 2013. Patients were followed-up for a period of 12 months, evaluating the development of complications, reduction of gastric volume, and the weight loss associated with the surgery, as well as their impact on the improvement of comorbidities present at beginning of the study. RESULTS: There was a statistically a significantly reduction between the preoperative body mass index (BMI) and the BMI at 12 months after laparoscopic sleeve gastrectomy (p < 0.001), despite there being an increase in the gastric volume during follow-up, measured at one month and 12 months after surgery (p < 0.001). Five patients (6.85%) had complications, with none of them serious and with no deaths in the whole series. CONCLUSIONS: Laparoscopic sleeve gastrectomy is a safe and effective technique for the treatment of morbid obesity. Its use is associated with a significant reduction in the presence of comorbidities associated with obesity. Multicentre studies with a longer period of monitoring are required to confirm the efficacy and safety of this surgical technique.
No takes yet. Share an insight, caveat, or question.
García-Díaz et al. (2016) conducted a cohort in morbid obesity (n=73). Laparoscopic sleeve gastrectomy was evaluated on reduction in body mass index (BMI) at 12 months (p=< 0.001). Laparoscopic sleeve gastrectomy significantly reduced body mass index at 12 months (p < 0.001) despite an increase in gastric volume, with a 6.85% complication rate.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: